Elevated risperidone serum concentrations during acute inflammation, two cases. (October 2015)

• Record Type: Journal Article
• Authors: Hefner, Gudrun; Falter, Tanja; Bruns, Kai; Hiemke, Christoph
• Is Part Of: International journal of psychiatry in medicine. Volume 50:Number 3(2015)
• Page Start: 335
• Page End: 344
• Publication Date: 2015-10
• Subjects: Inflammation -- cytochrome P450 -- risperidone -- pharmacokinetics -- intoxication; Psychiatry -- Periodicals; Sick -- Psychology -- Periodicals; Medicine, Psychosomatic -- Periodicals; 616.89005
• DOI: 10.1177/0091217415610313
• Languages: English
• ISSNs: 0091-2174

Abstract

Inflammation-mediated changes in drug metabolism may lead to alterations in the absorption, distribution, and clearance of psychotropic drugs and thus elevate drug levels in blood and lead to intoxications. We report about two patients who developed an up to threefold increase of dose-related serum concentrations of risperidone's active moiety (risperidone plus 9-hydroxyrisperidone) during acute inflammation indicated by elevated C-reactive protein. The two female patients (aged 56 and 38 years, respectively) had the diagnoses of paranoid schizophrenia and schizoaffective disorder. For both patients, there was a close time-dependent parallel fluctuation of drug levels and C-reactive protein. Since elevated drug levels could not be attributed to prescribed comedications, it seemed likely that high-serum concentrations of risperidone were due to inflammation. It is concluded that elevated C-reactive protein should be considered as an indication to control blood levels of risperidone and possibly dose adaption.